INCR.U:CC - InterCure to Participate in ROTH Capital's 34th Annual Conference
NEW YORK, TORONTO, and HERZLIYA, Israel, March 15, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in ROTH Capital’s 34 th Annual Conference, taking place March 15, 2022.
Mr. Rabinovitch will take part in the One-on-One Fireside Chat: Tuesday, March 15th, 2022 at 9:30 AM PT.
About InterCure (dba Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.
For more information, visit: http://www.intercure.co .
Contact:
InterCure Ltd.
Amos Cohen, Chief Financial Officer
amos@intercure.co